{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:45:48Z","timestamp":1764510348795},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/s11894-008-0022-y","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T16:15:52Z","timestamp":1205770552000},"page":"60-65","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Hepatic complications of hematopoietic cell transplantation"],"prefix":"10.1007","volume":"9","author":[{"given":"Josh","family":"Levitsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F.","family":"Sorrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,18]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/hep.20529","volume":"41","author":"T.A. Gooley","year":"2005","unstructured":"Gooley TA, Rajvanshi P, Schoch HG, McDonald GB: Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation. Hepatology 2005, 41:345\u2013352.","journal-title":"Hepatology"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1080\/1042819021000032962","volume":"43","author":"M.R. Litzow","year":"2002","unstructured":"Litzow MR, Repoussis PD, Schroeder G, et al.: Venoocclusive disease of the liver after blood and marrow transplantation: analysis of pre-and post-transplant risk factors associated with severity and results of therapy with tissue plasminogen activator. Leuk Lymphoma 2002, 43:2099\u20132107.","journal-title":"Leuk Lymphoma"},{"key":"22_CR3","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1182\/blood.V93.10.3259.410k13_3259_3266","volume":"93","author":"S.I. Strasser","year":"1999","unstructured":"Strasser SI, Sullivan KM, Myerson D, et al.: Cirrhosis of the liver in long-term marrow transplant survivors. Blood 1999, 93:3259\u20133266.","journal-title":"Blood"},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/00007890-199504000-00017","volume":"59","author":"H.M. Shulman","year":"1995","unstructured":"Shulman HM, Gooley T, Dudley MD, et al.: Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation 1995, 59:1015\u20131022.","journal-title":"Transplantation"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1182\/blood.V99.7.2324","volume":"99","author":"G.K. Lau","year":"2002","unstructured":"Lau GK, Leung YH, Fong DY, et al.: High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation. Blood 2002, 99:2324\u20132230.","journal-title":"Blood"},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/00007890-200207270-00007","volume":"74","author":"P.M. Chen","year":"2002","unstructured":"Chen PM, Yao NS, Wu CM, et al.: Detection of reactivation and genetic mutations of the hepatitis B virus in patients with chronic hepatitis B infections receiving hematopoietic stem cell transplantation. Transplantation 2002, 74:182\u2013188.","journal-title":"Transplantation"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/S0168-8278(99)80214-1","volume":"31","author":"C. Ustun","year":"1999","unstructured":"Ustun C, Idilman R, Gurman G, et al.: Hematopoietic stem cell transplantation from non-replicative hepatitis B virus carriers is safe. J Hepatol 1999, 31:202\u2013209.","journal-title":"J Hepatol"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1053\/jhep.2002.35068","volume":"36","author":"G.K. Lau","year":"2002","unstructured":"Lau GK, He ML, Fong DY, et al.: Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation. Hepatology 2002, 36:702\u2013709.","journal-title":"Hepatology"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ajh.10084","volume":"70","author":"M. Nakagawa","year":"2002","unstructured":"Nakagawa M, Simizu Y, Suemura M, Sato B: Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-Hodgkin\u2019s lymphoma: experience of 2 cases. Am J Hematol 2002, 70:60\u201363.","journal-title":"Am J Hematol"},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/sj.bmt.1702532","volume":"26","author":"J.F. Tomas","year":"2000","unstructured":"Tomas JF, Pinilla I, Garcia-Buey ML, et al.: Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients. Bone Marrow Transplant 2000, 26:649\u2013655.","journal-title":"Bone Marrow Transplant"},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/hep.510290609","volume":"29","author":"S.I. Strasser","year":"1999","unstructured":"Strasser SI, Myerson D, Spurgeon CL, et al.: Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up. Hepatology 1999, 29:1893\u20131899.","journal-title":"Hepatology"},{"key":"22_CR12","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1182\/blood.V83.7.1998.1998","volume":"83","author":"N. Frickhofen","year":"1994","unstructured":"Frickhofen N, Wiesneth M, Jainta C, et al.: Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation. Blood 1994, 83:1998\u20132004.","journal-title":"Blood"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1182\/blood-2003-06-2145","volume":"103","author":"D.L. Peffault","year":"2004","unstructured":"Peffault DL, Levy V, Asselah T, et al.: Long-term outcome of hepatitis C infection after bone marrow transplantation. Blood 2004, 103:1618\u20131624.","journal-title":"Blood"},{"key":"22_CR14","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1182\/blood.V86.4.1614.bloodjournal8641614","volume":"86","author":"P. Ljungman","year":"1995","unstructured":"Ljungman P, Johansson N, Aschan J, et al.: Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood 1995, 86:1614\u20131618.","journal-title":"Blood"},{"key":"22_CR15","first-page":"523","volume":"13","author":"Y. Fujii","year":"1994","unstructured":"Fujii Y, Kaku K, Tanaka M, et al.: Hepatitis C virus infection and liver disease after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994, 13:523\u2013526.","journal-title":"Bone Marrow Transplant"},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/sj.bmt.1700968","volume":"20","author":"C. Giardini","year":"1997","unstructured":"Giardini C, Galimberti M, Lucarelli G, et al.: Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia. Bone Marrow Transplant 1997, 20:767\u2013772.","journal-title":"Bone Marrow Transplant"},{"key":"22_CR17","first-page":"41","volume":"40","author":"D. Gruson","year":"1998","unstructured":"Gruson D, Hilbert G, Le Bail B, et al.: Fulminant hepatitis due to herpes simplex virus-type 2 in early phase of bone marrow transplantation. Hematol Cell Ther 1998, 40:41\u201344.","journal-title":"Hematol Cell Ther"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S1083-8791(00)70051-6","volume":"6","author":"Y. Koc","year":"2000","unstructured":"Koc Y, Miller KB, Schenkein DP, et al.: Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant, 2000, 6:44\u201349.","journal-title":"Biol Blood Marrow Transplant"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/sj.bmt.1702340","volume":"25","author":"T. Yagi","year":"2000","unstructured":"Yagi T, Karasuno T, Hasegawa T, et al.: Acute abdomen without cutaneous signs of varicella zoster virus infection as a late complication of allogeneic bone marrow transplantation: importance of empiric therapy with acyclovir. Bone Marrow Transplant 2000, 25:1003\u20131005.","journal-title":"Bone Marrow Transplant"},{"key":"22_CR20","first-page":"363","volume-title":"Pathology of the Liver","author":"S.B. Lucas","year":"2002","unstructured":"Lucas SB: Other viral and infectious diseases and HIV-related liver disease. In Pathology of the Liver. Edited by MacSween RNM, Burt AD, Portmann BC, et al.: Edinburg: Churchill Livingstone, 2002:363\u2013414."},{"key":"22_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1046\/j.1365-2141.2001.03087.x","volume":"115","author":"Y. Hoshino","year":"2001","unstructured":"Hoshino Y, Kimura H, Tanaka N, et al.: Prospective monitoring of the Epstein-Barr virus DNA by a real-time quantitative polymerase chain reaction after allogenic stem cell transplantation. Br J Haematol 2001, 115:105\u2013111.","journal-title":"Br J Haematol"},{"key":"22_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/JCM.40.2.351-358.2002","volume":"40","author":"B.C. Gartner","year":"2002","unstructured":"Gartner BC, Schafter H, Marggraff K, et al.: Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor post-transplant lymphoproliferative disease. J Clin Microbiol 2002, 40:351\u2013358.","journal-title":"J Clin Microbiol"},{"key":"22_CR23","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1182\/blood.V86.9.3598.bloodjournal8693598","volume":"86","author":"R.A. Bowden","year":"1995","unstructured":"Bowden RA, Slichter SJ, Sayers M, et al.: A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995, 86:3598\u20133603.","journal-title":"Blood"},{"key":"22_CR24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1086\/367836","volume":"36","author":"D.J. Winston","year":"2003","unstructured":"Winston DJ, Yeager AM, Chandrasekar PH, et al.: Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation. Clin Infect Dis 2003, 36:749\u2013758.","journal-title":"Clin Infect Dis"},{"key":"22_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1080\/146532402317251491","volume":"4","author":"K.S. Peggs","year":"2002","unstructured":"Peggs KS, Mackinnon S: Clinical trials with CMV-specific T cells. Cytotherapy 2002, 4:21\u201328.","journal-title":"Cytotherapy"},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0037-1963(03)70007-9","volume":"40","author":"D.A. Clark","year":"2003","unstructured":"Clark DA, Emery VC, Griffiths PD: Cytomegalovirus, human herpesvirus-6, and human herpesvirus-7 in hematological patients. Semin Hematol 2003, 40:154\u2013162.","journal-title":"Semin Hematol"},{"key":"22_CR27","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.5858\/2003-127-e246-FAHFBM","volume":"127","author":"W.H. Wang","year":"2003","unstructured":"Wang WH, Wang HL: Fulminant adenovirus hepatitis following bone marrow transplantation. A case report and brief review of the literature. Arch Pathol Lab Med, 2003 127:e246\u2013e248.","journal-title":"Arch Pathol Lab Med"},{"key":"22_CR28","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood.V89.10.3853","volume":"89","author":"S.J. Skidmore","year":"1997","unstructured":"Skidmore SJ, Collingham KE, Harrison P, et al.: High prevalence of hepatitis G virus in bone marrow transplant recipients and patients treated for acute leukemia. Blood 1997, 89:3853\u20133856.","journal-title":"Blood"},{"key":"22_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1046\/j.1365-2893.1997.00128.x","volume":"4","author":"P. Karayiannis","year":"1997","unstructured":"Karayiannis P, Hadziyannis SJ, Kim J, et al.: Hepatitis G virus infection: clinical characteristics and response to interferon. J Viral Hepat 1997, 4:37\u201344.","journal-title":"J Viral Hepat"},{"key":"22_CR30","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S0016-5085(97)70250-6","volume":"112","author":"R.H. Moseley","year":"1997","unstructured":"Moseley RH: Sepsis-associated cholestasis. Gastroenterology 1997, 112:302\u2013306.","journal-title":"Gastroenterology"},{"key":"22_CR31","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/sj.bmt.1702233","volume":"25","author":"S.N. Wolff","year":"2000","unstructured":"Wolff SN, Fay J, Stevens D, et al.: Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group. Bone Marrow Transplant 2000, 25:853\u2013859.","journal-title":"Bone Marrow Transplant"},{"key":"22_CR32","first-page":"21","volume":"11","author":"E. Carreras","year":"1993","unstructured":"Carreras E, Granena A, Navasa M, et al.: Transjugular liver biopsy in BMT. Bone Marrow Transplant 1993, 11:21\u201326.","journal-title":"Bone Marrow Transplant"},{"key":"22_CR33","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","volume":"100","author":"T. Ruutu","year":"2002","unstructured":"Ruutu T, Eriksson B, Remes K, et al.: Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation. Blood 2002, 100:1977\u20131983.","journal-title":"Blood"},{"key":"22_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/00007890-198403000-00005","volume":"37","author":"M.D. Kanojia","year":"1984","unstructured":"Kanojia MD, Anagnostou AA, Zander AR, et al.: High-dose methylprednisolone treatment for acute graft-versus-host disease after bone marrow transplantation in adults. Transplantation 1984, 37:246\u2013249.","journal-title":"Transplantation"},{"key":"22_CR35","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1053\/jhep.2000.20067","volume":"32","author":"S.I. Strasser","year":"2000","unstructured":"Strasser SI, Shulman HM, Flowers ME, et al.: Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis. Hepatology 2000, 32:1265\u20131271.","journal-title":"Hepatology"},{"key":"22_CR36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/lt.20389","volume":"11","author":"N.R. Barshes","year":"2005","unstructured":"Barshes NR, Myers GD, Lee D, et al.: Liver transplantation for severe hepatic graft-versus-host disease: An analysis of aggregate survival data. Liver Transpl 2005, 11:525\u2013531.","journal-title":"Liver Transpl"},{"key":"22_CR37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","volume":"118","author":"G.B. McDonald","year":"1993","unstructured":"McDonald GB, Hinds MS, et al.: Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993, 118:255\u2013267.","journal-title":"Ann Intern Med"},{"key":"22_CR38","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/00007890-199504000-00017","volume":"59","author":"H.M. Shulman","year":"1995","unstructured":"Shulman HM, Gooley T, Dudley MD, et al.: Utility of transvernous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation 1995, 59:1015\u20131022.","journal-title":"Transplantation"},{"key":"22_CR39","first-page":"549","volume":"127","author":"H.M. Shulman","year":"1987","unstructured":"Shulman HM, Gown AM, Nugent DJ: Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. Am J Pathol 1987, 127:549\u2013558.","journal-title":"Am J Pathol"},{"key":"22_CR40","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1345\/aph.10220","volume":"35","author":"A.A. Pegram","year":"2001","unstructured":"Pegram AA, Kennedy LD: Prevention and treatment of veno-occlusive disease. Ann Pharmacother 2001, 35:935\u2013942.","journal-title":"Ann Pharmacother"},{"key":"22_CR41","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1182\/blood-2002-04-1216","volume":"100","author":"P.G. Richardson","year":"2002","unstructured":"Richardson PG, Murakami C, Jin Z, et al.: Multi-institutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ failure: response without significant toxicity in a high-risk population and factors predictive of outcome. Blood 2002, 100:4337\u20134343.","journal-title":"Blood"},{"key":"22_CR42","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.bmt.1704329","volume":"33","author":"S. Corbacioglu","year":"2004","unstructured":"Corbacioglu S, Greil J, Peters C, et al.: Defibrotide in the treatment of children with veno-occlusive disease (VOD): a retrospective multicentre study demonstrates therapeutic efficacy upon early intervention. Bone Marrow Transplant 2004, 33:189\u2013195.","journal-title":"Bone Marrow Transplant"},{"key":"22_CR43","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1182\/blood.V90.3.994","volume":"90","author":"E. Angelucci","year":"1997","unstructured":"Angelucci E, Muretto P, Lucarelli G, et al.: Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients. Blood 1997, 90:994\u2013998.","journal-title":"Blood"},{"key":"22_CR44","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/sj.bmt.1701665","volume":"23","author":"C.S. Murakami","year":"1999","unstructured":"Murakami CS, Louie W, Chan GS, et al.: Biliary obstruction in hematopoietic cell transplant recipients: an uncommon diagnosis with specific causes. Bone Marrow Transplant 1999, 23:921\u2013927.","journal-title":"Bone Marrow Transplant"},{"key":"22_CR45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/hep.1840090317","volume":"9","author":"D.C. Snover","year":"1989","unstructured":"Snover DC, Weisdorf S, Bloomer J, et al.: Nodular regenerative hyperplasia of the liver following bone marrow transplantation. Hepatology 1989, 9:443\u2013448.","journal-title":"Hepatology"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-008-0022-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-008-0022-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-008-0022-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-008-0022-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:06:36Z","timestamp":1659089196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-008-0022-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s11894-008-0022-y","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"18 March 2008","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}